MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ppul.22609

Медицинская библиотека · Pediatric pulmonology · 2012

Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia.

Collaco Joseph M, Romer Lewis H, Stuart Bridget D, Coulson John D, Everett Allen D, Lawson Edward E, Brenner Joel I, Brown Anna T, Nies Melanie K, Sekar Priya, Nogee Lawrence M, McGrath-Morrow Sharon A

СтатьяОбзорПеревод в очереди

Аннотация

Pulmonary hypertension (PH) is an increasingly recognized complication of premature birth and bronchopulmonary dysplasia (BPD), and is associated with increased morbidity and mortality. Extreme phenotypic variability exists among preterm infants of similar gestational ages, making it difficult to predict which infants are at increased risk for developing PH. Intrauterine growth retardation or drug exposures, postnatal therapy with prolonged positive pressure ventilation, cardiovascular shunts, poor postnatal lung and somatic growth, and genetic or epigenetic factors may all contribute to the development of PH in preterm infants with BPD. In addition to the variability of severity of PH, there is also qualitative variability seen in PH, such as the variable responses to vasoactive medications. To reduce the morbidity and mortality associated with PH, a multi-pronged approach is needed. First, improved screening for and increased recognition of PH may allow for earlier treatment and better clinical outcomes. Second, identification of both prenatal and postnatal risk factors for the development of PH may allow targeting of therapy and resources for those at highest risk. Third, understanding the pathophysiology of the preterm pulmonary vascular bed may help improve outcomes through recognizing pathways that are dysregulated in PH, identifying novel biomarkers, and testing novel treatments. Finally, the recognition of conditions and exposures that may exacerbate or lead to recurrent PH is needed to help with developing treatment guidelines and preventative strategies that can be used to reduce the burden of disease.

Для цитирования: Collaco Joseph M, Romer Lewis H, Stuart Bridget D, Coulson John D, Everett Allen D, Lawson Edward E, Brenner Joel I, Brown Anna T, Nies Melanie K, Sekar Priya, Nogee Lawrence M, McGrath-Morrow Sharon A. Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia.. Pediatric pulmonology. 2012. DOI: 10.1002/ppul.22609.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.